Literature DB >> 20599528

Antioxidant idebenone-loaded nanoparticles based on chitosan and N-carboxymethylchitosan.

Clarissa de M Amorim1, Angélica G Couto, Daisy J A Netz, Rilton A de Freitas, Tania M B Bresolin.   

Abstract

Nanoparticles based on chitosan (Ch) and N-carboxymethylchitosan (N-CMCh) cross-linked with tripolyphosphate (TPP) were developed by co-drying with idebenone in different polymer-to-drug ratios (1.3:1 to 16:1) with 20% (wt/wt) colloidal silicon dioxide and tripolyphosphate (0.2 mg/mL). At high ratios (8:1 and 16:1) the spray-dried powder showed spherical and dense particles with a size close to 1 μm, allowing almost complete drug coating by the polymeric system and a high efficiency of drug incorporation (>90% and >80%, for Ch and N-CMCh, respectively). The nanoparticles showed a 10-fold increase of drug stability in comparison with free drug and preserved antioxidant activity in vitro. Compared with the severely irritative free form of idebenone, the nanoparticle formulation showed decreased mucous membrane irritation. These results revealed the potential of Ch and N-CMCh nanoparticles as carriers for a hydrophobic and irritative drug such as idebenone for topical or nasal use.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20599528     DOI: 10.1016/j.nano.2010.06.006

Source DB:  PubMed          Journal:  Nanomedicine        ISSN: 1549-9634            Impact factor:   5.307


  9 in total

1.  New strategy to surface functionalization of polymeric nanoparticles: one-pot synthesis of scFv anti-LDL(-)-functionalized nanocapsules.

Authors:  Eduardo A Bender; Marcela F Cavalcante; Márcia D Adorne; Letícia M Colomé; Sílvia S Guterres; Dulcinéia S P Abdalla; Adriana R Pohlmann
Journal:  Pharm Res       Date:  2014-05-08       Impact factor: 4.200

2.  Nanostructured lipid carriers improve skin permeation and chemical stability of idebenone.

Authors:  Bei Li; Zhi-Qiang Ge
Journal:  AAPS PharmSciTech       Date:  2012-01-11       Impact factor: 3.246

Review 3.  Strategies to reduce the tampering and subsequent abuse of long-acting opioids: potential risks and benefits of formulations with physical or pharmacologic deterrents to tampering.

Authors:  Steven P Stanos; Patricia Bruckenthal; Robert L Barkin
Journal:  Mayo Clin Proc       Date:  2012-07       Impact factor: 7.616

4.  Purinoceptor Targeted Cytotoxicity of Adenosine Triphosphate-Conjugated Biogenic Selenium Nanoparticles in Human Colon Cancer Cells.

Authors:  Kandasamy Saravanakumar; Anbazhagan Sathiyaseelan; Xin Zhang; Soyoung Park; Myeong-Hyeon Wang
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-06

Review 5.  Nanotechnology inspired tools for mitochondrial dysfunction related diseases.

Authors:  Ru Wen; Bhabatosh Banik; Rakesh K Pathak; Anil Kumar; Nagesh Kolishetti; Shanta Dhar
Journal:  Adv Drug Deliv Rev       Date:  2016-01-09       Impact factor: 15.470

6.  Novel spray-dried genipin-crosslinked casein nanoparticles for prolonged release of alfuzosin hydrochloride.

Authors:  Ahmed O Elzoghby; Wael M Samy; Nazik A Elgindy
Journal:  Pharm Res       Date:  2012-11-08       Impact factor: 4.200

Review 7.  Idebenone: Novel Strategies to Improve Its Systemic and Local Efficacy.

Authors:  Lucia Montenegro; Rita Turnaturi; Carmela Parenti; Lorella Pasquinucci
Journal:  Nanomaterials (Basel)       Date:  2018-02-05       Impact factor: 5.076

Review 8.  Nanotechnology-based drug delivery systems for the treatment of Alzheimer's disease.

Authors:  Bruno Fonseca-Santos; Maria Palmira Daflon Gremião; Marlus Chorilli
Journal:  Int J Nanomedicine       Date:  2015-08-04

9.  Facile Solvent-Free Preparation of Antioxidant Idebenone-Loaded Nanoparticles for Efficient Wound Healing.

Authors:  HeeSeon Yang; Sohyeon Yu; Jisu Kim; KumJu Baek; Young-Ran Lee; Hye Sun Lee; Won Il Choi; Daekyung Sung
Journal:  Pharmaceutics       Date:  2022-02-26       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.